GV-971, a multi-targeting oligosaccharide drug developed by a Chinese research group, could give Alzheimer patients hope, lead researcher Geng Meiyu told.
SENEGAL | DAKAR：03.14 06:49
NIGERIA | LAGOS：03.14 07:49
EGYPT | CAIRO：03.14 08:49
UAE | DUBAI：03.14 10:49
SRI LANKA | COLOMBO：03.14 12:19
SINGAPORE：03.14 14:49
ENGLAND | LONDON：03.14 07:49
RUSSIA | MOSCOW：03.14 10:49
CHINA | BEIJING：03.14 14:49
AMERICA | Los Angels：03.13 23:49
AMERICA | New York：03.14 02:49
BRAZIL | San Paulo：03.14 03:49
.jpg)